Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

TScan Therapeutics (TCRX) Preferred Shares Issued (2021)

TScan Therapeutics (TCRX) has disclosed Preferred Shares Issued for 1 consecutive years, with $99.7 million as the latest value for Q1 2021.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $99.7 million in Q1 2021 year-over-year; TTM through Dec 2021 was $99.7 million, a N/A change, with the full-year FY2021 number at $99.7 million, changed N/A from a year prior.
  • Preferred Shares Issued was $99.7 million for Q1 2021 at TScan Therapeutics.
  • In the past five years, Preferred Shares Issued ranged from a high of $99.7 million in Q1 2021 to a low of $99.7 million in Q1 2021.